Contract 75N98C21K00031
Molecular Instruments, Inc · Department Of Health And Human Services · August 18, 2021
Molecular Instruments, Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 18, 2021 for $20,000 of work in biological product (except diagnostic) manufacturing. Performance is in Los Angeles, CA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N98C21K00031
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Chemicals
- Place of performance
- Los Angeles, CA
- First action
- August 18, 2021
Description
MOLECULAR INSTRUMENTS, INC. [21-002649]
Modification timeline
-
August 18, 2021Base award$20.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N98C21K00031?
Contract 75N98C21K00031 is a federal contract awarded to Molecular Instruments, Inc by Department Of Health And Human Services on August 18, 2021 for $20,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N98C21K00031?
Molecular Instruments, Inc won contract 75N98C21K00031 from Department Of Health And Human Services.
How much is contract 75N98C21K00031 worth?
Contract 75N98C21K00031 has obligated $20,000 to date.